Table 6.
Univariate analysis for prognostic parameters in 65 invasive breast carcinomas for 5-year survival rate
| Variable | n | 5-year survival rate (%) | P value |
|---|---|---|---|
| Age (years) | 0.644 | ||
| ≤35 | 5 | 60.00 | |
| >35 | 60 | 70.00 | |
| Menstrual status | 0.411 | ||
| Pre-menopausal | 44 | 72.73 | |
| Post-menopausal | 21 | 61.90 | |
| Tumor size (cm) | 0.525 | ||
| ≤2 | 22 | 63.64 | |
| >2 | 43 | 72.09 | |
| Lymph node metastasis | 0.048* | ||
| Negative | 32 | 84.38 | |
| Positive | 33 | 54.55 | |
| Clinical stage | 0.007* | ||
| I-II | 33 | 81.82 | |
| III | 32 | 56.25 | |
| Receptor status | 0.012* | ||
| TNBC | 13 | 36.36 | |
| Non-TNBC | 52 | 77.78 | |
| ALDH1 status | 0.012* | ||
| ALDH1+ | 40 | 57.50 | |
| ALDH1- | 25 | 88.00 | |
| TGFβ2 status | 0.023* | ||
| TGFβ2+ | 42 | 59.52 | |
| TGFβ2- | 23 | 86.96 | |
*
P<0.05.